GW
TAK icon

GW & Wade’s Takeda Pharmaceutical TAK Stock Holding History

GW & Wade’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-56,271
Closed -$730K – 408
2022
Q3 		$730K Buy
56,271
+989
+2% +$13.8K 0.04% 200
2022
Q2 		$776K Hold
55,282
– – 0.04% 208
2022
Q1 		$792K Buy
+55,282
New +$812K 0.03% 204
2021
Q1 		– Sell
-52,965
Closed -$964K – 362
2020
Q4 		$964K Hold
52,965
– – 0.06% 144
2020
Q3 		$945K Buy
+52,965
New +$964K 0.07% 120

Other funds holding TAK

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

GW & Wade's TAK Position: Q4 2022 in Review

GW & Wade sold out of Takeda Pharmaceutical (TAK) in Q4 2022, closing a stake of 56,271 shares — an estimated $730K sold.

GW & Wade first reported a position in TAK in Q3 2020 and held it in 5 quarters. The position peaked at $964K in Q4 2020. 281 funds tracked by Wall St. Rank hold TAK as of Q4 2022.

  • GW & Wade reported no remaining Takeda Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • GW & Wade sold 56,271 Takeda Pharmaceutical shares in Q4 2022, an estimated $730K.
  • GW & Wade first reported a position in Takeda Pharmaceutical in Q3 2020 and held it in 5 quarters.
  • GW & Wade's Takeda Pharmaceutical position peaked at $964K in Q4 2020.
  • 281 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2022.

Based on GW & Wade's 13F filing for Q4 2022, filed 10 Feb 2023.